ReproAlign

AI-Powered Fertility & IVF Software for clinics and labs

health AIfertility techmedtech

Visit website LinkedIn ↗

Stageunfunded

Raised$0

Founded2025

Employees5

LocationSan Francisco, CA

Business modelB2B, SaaS, API integrations

About

ReproAlign - AI Suite for Fertility Clinics & Women’s Health IVF Automation • Clinical Intelligence • Emotional AI ReproAlign is an AI-driven fertility technology company building the world’s first Fertility Operating System (Fertility OS), an intelligent platform that unifies clinical, lab, and patient data to optimize IVF outcomes. Our suite of AI copilots empowers fertility clinics, embryologists, and patients through predictive insights, workflow automation, and emotional support. By integrating AI, reproductive science, and human empathy, ReproAlign transforms fragmented fertility care into an intelligent, interconnected system. We help clinics increase IVF success rates, reduce human error, and deliver personalized reproductive care at scale. Founded by embryologists and AI engineers, ReproAlign’s mission is to redefine fertility as a continuous, data-intelligent, emotionally supported journey empowering life creation through precision, compassion, and technology.

Product

Value proposition: A comprehensive AI platform that analyzes fertility data, provides predictive insights, and personalizes care pathways to improve IVF success rates while integrating with existing EMR and lab systems.
Target customers: Fertility clinics and IVF laboratories
Regulatory: US healthcare startup with HIPAA readiness; regulatory pathway not fully specified

Founders

Aparna Satheesh R — Co-Founder & CEO
Adarsh Johny — Co-Founder & Head of Engineering & AI
Rajeev Krishnan — Co-Founder & Head of Product

Products

Fertility OSAI modules suiteReproAlign API for EMR/Lab integrationElora patient portal/dashboard

Key features

Centralized analytics hubPatient journey trackingCross-module data synthesisAI-powered sperm analysis (motility, morphology)Embryo/implantation scoring and gradingPloidy risk detection with time-lapse integrationReceptivity and synchrony scoringPersonalized timing alertsAI-driven nutrition and lifestyle guidanceSecure clinic communicationHIPAA/GDPR compliant data handlingReal-time data synchronization with EMRs/lab systemsHuman-in-the-Loop verificationDedicated IT support during implementation

Technologies

AI/MLPredictive analyticsTime-lapse imagingSperm analysisData integrationAPIsSecure data transmissionRole-based access controlmulti-factor authentication

Integrations

EMR systemslab softwareReproAlign APIElora patient dashboard

Target conditions

infertilityIVF failurereproductive health disorders

Care settings

cliniclabhospitalvirtual

Certifications

HIPAAGDPR ready

News

REPRONOVO RAISES $65 MILLION SERIES A FINANCING TO ADVANCE PHASE 2 CLINICAL TRIALS OF NOVEL THERAPIES IN REPRODUCTIVE MEDICINE AND WOMEN’S HEALTH - ReproNovo · 2025-05-21T05:00:59.000Z
Startups to watch: ReproHealth Technologies – Indianapolis Business Journal · 2025-05-09T18:00:00.000Z
Reprotech and TMRW Life Sciences enter into Business Combination to Create the Most Comprehensive Technology-Enabled Cryostorage Company in Fertility · 2026-04-02T13:00:00.000Z
ReproTech LLC ("ReproTech") has made a significant growth investment in Matcher Technologies Ltd ("Matcher") to support its expansion across the fertility sector · 2025-06-09T13:00:00.000Z
Repronovo raises $65 million in series A - BioAlps · 2025-05-22T19:10:06.000Z
Reprotech and TMRW Life Sciences Combine to Create Largest Tech-Enabled Fertility Cryostorage Company | Femtech Insider · 2026-04-08T08:50:12.000Z